Skip to main content
. 2019 Mar 1;14:585–595. doi: 10.2147/COPD.S195438

Figure 1.

Figure 1

Percentage of patients within bins of peak inspiratory flow (PIFR), measured against R2 low–medium resistance inhaler (eg, Diskus® and Ellipta®; blue) and R5 high resistance inhaler (Handihaler®; orange).